Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05911087
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-20
First Post:
2023-06-18
Brief Title:
A Phase IIIII Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2
Sponsor:
Stemirna Therapeutics
Organization:
Stemirna Therapeutics
Organization Data
Organization:
Stemirna Therapeutics
Class:
INDUSTRY
Study ID:
SWP2023-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Stemirna Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None